Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

In addition to remarkable antitumor activity, chimeric antigen receptor (CAR) T-cell therapy is associated with acute toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Current treatment guidelines for CRS and ICANS include use of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrli, Marc, Gallagher, Kathleen, Chen, Yi-Bin, Leick, Mark B, McAfee, Steven L, El-Jawahri, Areej R, DeFilipp, Zachariah, Horick, Nora, O'Donnell, Paul, Spitzer, Thomas, Dey, Bimal, Cook, Daniella, Trailor, Michael, Lindell, Kevin, Maus, Marcela V, Frigault, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744112/
https://www.ncbi.nlm.nih.gov/pubmed/34996813
http://dx.doi.org/10.1136/jitc-2021-003847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744112/
https://www.ncbi.nlm.nih.gov/pubmed/34996813
http://dx.doi.org/10.1136/jitc-2021-003847

Ejemplares similares